Document:

Document

AMENDED AND RESTATED AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT             

             This Amended and Restated Amendment No. 1 (“Amended and Restated Amendment No. 1”) to Employment Agreement is entered into between Ted Smith (“Executive”) and Nuvve Holding Corp. (the “Company”) to amend Executive’s Employment Agreement dated as of March 19, 2021 (the “Employment Agreement’). This Amended and Restated Amendment No. 1 is effective as of August 10, 2022 (the “Effective Date”), as amended and restated on November 11, 2022.

WHEREAS, the Company has employed Executive pursuant to the Employment Agreement; and 

WHEREAS, the Company and Executive have agreed that it is mutually beneficial to the Company and Executive to amend and modify certain compensation components in the Employment Agreement as provided herein.

NOW, THEREFORE, in consideration of the foregoing and the covenants in this Amendment No. 1, the parties agree as follows:

1.Section 3(a) of the Employment Agreement (and elsewhere where appropriate, except as provided herein) is amended to provide for a Base Salary rate of $401,625 per annum, which adjusted Base Salary shall apply for the period from  September 1, 2022 through August 31, 2023 (the “New Salary Period”).

1.Notwithstanding the foregoing, for purposes of Sections 5(d) and 5(e) of the Employment Agreement, Executive’s Base Salary shall be calculated as if Executive was earning $446,250 per annum (the “Adjusted Base Salary”) as of the date of any separation of service that would qualify Executive for severance eligibility under Sections 5(d) or 5(e).

1.In further consideration of this Amended and Restated Amendment No. 1, on August 12, 2022, the Company granted Executive a number of RSUs equal to $44,625 in shares of the Company’s common stock based on a value per share equal to the closing price of the Company’s common stock on the date of grant of the RSUs (rounded up to the nearest whole share) vesting monthly at the end of each month over the course of the New Salary Period (the “Original RSU Award”), portions of which vested on September 30, 2022 in the amount of 925 shares equal to a value of $1,295 on the vesting date based on the number of shares vesting on the vesting date multiplied by the closing price of the Company’s common stock on the vesting date (the “Vesting Date Value”) and October 31, 2022 in the amount of 925 shares equal to a Vesting Date Value of $943.50. On November 11, 2022, the Company and Executive agree that the unvested portions of the Original RSU Award shall be cancelled, effective as of the same date, and the Company has agreed to grant Executive the replacement stock awards on the grant dates and in the amounts set forth in the table below (the “Replacement Grants”). The Replacement Grants shall be issued pursuant to the Company’s 2020 Equity Incentive Plan on each of the dates set forth in the table below (each, a “Grant Date”), each such grant to equal a number of shares of fully vested common stock calculated as the dollar value set forth in the table below divided by the closing price of the Company’s common stock on the applicable Grant Date (or, if the Grant Date is not a trading date, the closing price of the 

Company’s Common Stock on the most recent preceding trading date) (in each case rounded up to the nearest whole share), subject to Executive’s continued employment with the Company on the relevant Grant Date.
																														
	Grant Date
Nov. 30, 2022
	Grant Date
Dec. 31, 2022
	Grant Date
Jan. 31, 2023
	Grant Date
Feb. 28, 2023
	Grant Date
Mar. 31, 2023
	Grant Date
Apr. 30, 2023
	Grant Date
May 31, 2023
	Grant Date
June 30, 2023
	Grant Date
July 31, 2023
	Grant Date
Aug. 31, 2023

	$8,917.75(a)
	$3,718.75(b)
	$3,718.75
	$3,718.75
	$3,718.75
	$3,718.75
	$3,718.75
	$3,718.75
	$3,718.75
	$3,718.75

(a) Grant amount represents 1/12th of $44,625, plus a catch-up amount of $5,199 (representing the difference between the value of the equity compensation intended to be paid to Executive in September and October 2022 ($7,437.50) and the aggregate Vesting Date Value received.
(b) Grant amount represents 1/12th of $44,625. 

1.This Amended and Restated Amendment No. 1 is made and effective pursuant to Section 13(e) of the Employment Agreement. All other provisions of the Employment Agreement shall remain in full force and effect. 

1.This Amended and Restated Amendment No. 1 is effective as of the date written above.

/s/ Ted Smith                                                         Nuvve Holding Corp.

_____________________________                          By: __/s/ Gregory Poilasne_______
                                                                              Name: Gregory Poilasne
 Title: Chief Executive OfficerDocument

AMENDED AND RESTATED AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT             

             This Amended and Restated Amendment No. 1 (“Amended and Restated Amendment No. 1”) to Employment Agreement is entered into between David Robson (“Executive”) and Nuvve Holding Corp. (the “Company”) to amend Executive’s Employment Agreement dated as of March 19, 2021 (the “Employment Agreement’). This Amended and Restated Amendment No. 1 is effective as of August 10, 2022 (the “Effective Date”), as amended and restated on November 11, 2022.

WHEREAS, the Company has employed Executive pursuant to the Employment Agreement; and 

WHEREAS, the Company and Executive have agreed that it is mutually beneficial to the Company and Executive to amend and modify certain compensation components in the Employment Agreement as provided herein.

NOW, THEREFORE, in consideration of the foregoing and the covenants in this Amendment No. 1, the parties agree as follows:

1.Section 3(a) of the Employment Agreement (and elsewhere where appropriate, except as provided herein) is amended to provide for a Base Salary rate of $166,472 per annum, which adjusted Base Salary shall apply for the period from  September 1, 2022 through August 31, 2023 (the “New Salary Period”).

1.Executive agrees that the reduction of Base Salary herein is made with Executive’s consent and does not constitute a material reduction of Executive’s Base Salary as provided for in Section 5(h)(iii) or (iv) of the Employment Agreement.

1.Notwithstanding the foregoing, for purposes of Sections 5(d) and 5(e) of the Employment Agreement, Executive’s Base Salary shall be calculated as if Executive was earning (i) $420,000 per annum as of the date of any separation of service that would qualify Executive for severance eligibility under Sections 5(d) or 5(e).

1.In further consideration of this Amended and Restated Amendment No. 1, on August 12, 2022, the Company granted Executive a number of RSUs equal to $166,472 in shares of the Company’s common stock based on a value per share equal to the closing price of the Company’s common stock on the date of grant of the RSUs (rounded up to the nearest whole share) vesting monthly at the end of each month over the course of the New Salary Period (the “Original RSU Award”), portions of which vested on September 30, 2022 in the amount of 3,450 shares equal to a value of $4,830 on the vesting date based on the number of shares vesting on the vesting date multiplied by the closing price of the Company’s common stock on the vesting date (the “Vesting Date Value”) and on October 31, 2022 in the amount of 3,450 shares equal to a Vesting Date Value of $3,519. On November 11, 2022, the Company and Executive agree that the unvested portions of the Original RSU Award shall be cancelled, effective as of the same date, and the Company has agreed to grant Executive the replacement stock awards on the grant dates and in the amounts set forth in the table below (the “Replacement Grants”). The Replacement Grants shall be issued pursuant to the Company’s 2020 Equity Incentive 

Plan on each of the dates set forth in the table below (each, a “Grant Date”), each such grant to equal a number of shares of fully vested common stock calculated as the dollar value set forth in the table below divided by the closing price of the Company’s common stock on the applicable Grant Date (or, if the Grant Date is not a trading date, the closing price of the Company’s Common Stock on the most recent preceding trading date) (in each case rounded up to the nearest whole share), subject to Executive’s continued employment with the Company on the relevant Grant Date.
																														
	Grant Date
Nov. 30, 2022
	Grant Date
Dec. 31, 2022
	Grant Date
Jan. 31, 2023
	Grant Date
Feb. 28, 2023
	Grant Date
Mar. 31, 2023
	Grant Date
Apr. 30, 2023
	Grant Date
May 31, 2023
	Grant Date
June 30, 2023
	Grant Date
July 31, 2023
	Grant Date
Aug. 31, 2023

	$33,268.98(a)
	$13,872.66(b)
	$13,872.67
	$13,872.67
	$13,872.67
	$13,872.67
	$13,872.67
	$13,872.67
	$13,872.67
	$13,872.67

(a) Grant amount represents 1/12th of $166,472, plus a catch-up amount of $19,396.32 (representing the difference between the value of the equity compensation intended to be paid to Executive in September and October 2022 ($27,745.32) and the aggregate Vesting Date Value received.
(b) Grant amount represents 1/12th of $166,472.

1.This Amended and Restated Amendment No. 1 is made and effective pursuant to Section 13(e) of the Employment Agreement. All other provisions of the Employment Agreement shall remain in full force and effect. 

1.This Amended and Restated Amendment No. 1 is effective as of the date written above.

/s/ David Robson                                                                Nuvve Holding Corp.

_____________________________                          By: __/s/ Gregory Poilasne________
                                                                                  Name: Gregory Poilasne
  Title: Chief Executive Officer

						
		130995891v.4​

Exhibit 10.1
AMENDMENT NO. 3
TO
PROMISSORY NOTE
​
This AMENDMENT NO. 3 TO PROMISSORY NOTE (this “Amendment”) is dated as of November 14, 2022, by and among JIMMY JANG, L.P., a Delaware limited partnership and BAKER TECHNOLOGIES, INC., a Delaware corporation, JUPITER RESEARCH, LLC., an Arizona limited liability company, and COMMONWEALTH ALTERNATIVE CARE, INC., a Massachusetts corporation, together, joint and severally, the “Company”) and NR 1, LLC, a Delaware limited liability company, as noteholder representative (the “Noteholder Representative”).
WHEREAS, pursuant to that certain Senior Secured Note Purchase Agreement dated as of November 1, 2019 (the “Senior NPA”; capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Senior NPA) by and among the Company, the Noteholder and the investors party thereto (the “Purchasers”), the Company issued to such investors senior secured promissory notes in the aggregate principal amount of approximately $35.0 million (collectively, the “Notes”);
​
WHEREAS, the Company and certain Purchasers (collectively, the “Participating Noteholders”) entered into Amendment No. 1 to Promissory Note, pursuant to which the Maturity Date for the Notes held by such Participating Noteholders (the “Extended Notes”) was extended from November 1, 2022 to November 14, 2022 and the Applicable Interest Rate was amended; and
​
WHEREAS, the Notes may be further amended with the written consent of the Company and Noteholder Representative, and the Company and Noteholder Representative wish to amend the Notes as set forth below.
​
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
​
1.Amendment to Notes.  The Company and the Noteholder Representative hereby agree to extend the Maturity Date for the Extended Notes from November 14, 2022 to December 31, 2022.
​
2.Miscellaneous.
​
(a)Except as expressly set forth herein, the Note shall remain in full force and effect and this Amendment shall have no effect or impact on the other Notes outstanding under the Senior NPA.
​
(b)This Amendment will be governed by and construed in accordance with the internal laws of the Commonwealth of Massachusetts, without giving effect to the conflict of laws provisions thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction other than those of the Commonwealth of Massachusetts.
​

1

​

(c)This Amendment may be executed in any number of counterparts, each of which shall be deemed an original, but all of which when taken together shall constitute one and the same instrument.
​
[SIGNATURE PAGES FOLLOW]
​
​

2

​

IN WITNESS WHEREOF, the undersigned have executed this Amendment No. 3 to Promissory Note as of the date first written above.
​
THE COMPANY:
​
	​

	​

	​

	​
	JIMMY JANG, L.P., a Delaware limited partnership, by its General Partner, JIMMY JANG HOLDINGS INC., a British Columbia corporation

	​
	​

	​
	By
	/s/ Gary F. Santo, Jr.

	​
	Name:
	Gary F. Santo, Jr.

	​
	Title:
	President

​
​
	​
	BAKER TECHNOLOGIES, INC., a Delaware corporation

	​
	​

	​
	By
	/s/ Gary F. Santo, Jr.

	​
	Name:
	Gary F. Santo, Jr.

	​
	Title:
	President

​
	​

	​

	​

	​
	JUPITER RESEARCH, LLC, an Arizona limited liability company

	​
	​

	​
	By
	/s/ Gary F. Santo, Jr.

	​
	Name:
	Gary F. Santo, Jr.

	​
	Title:
	President

​
​
	/s/ Gary F. Santo, Jr.

	​

	​

	​
	COMMONWEALTH ALTERNATIVE CARE, INC., a Massachusetts corporation

	​
	​

	​
	By
	/s/ Gary F. Santo, Jr.

	​
	Name:
	Gary F. Santo, Jr.

	​
	Title:
	President

​
​
	​

	​

	​

	NOTEHOLDER REPRESENTATIVE:
	​

	​
	NR1, LLC

	​
	​

	​
	By:
	/s/ David Milner

	​
	Name:
	David Milner

	​
	Title:
	Authorized Signatory

​
​

3

​

Acknowledged and Agreed to:
​
	​

	​

	​

	TILT HOLDINGS INC., a British Columbia corporation
	​

	​
	​

	By
	/s/ Gary F. Santo, Jr.
	​

	Name:
	Gary F. Santo, Jr.
	​

	Title:
	Chief Executive Officer
	​

	Address:
	2801 E. Camelback Rd., Suite 180
	​

	​
	Phoenix, Az 85016
	​

​

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]